Research on the Linkage Mechanism between Essential Medicine List and Healthcare Insurance List
- 1 School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China
- 2 School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China
- 3 School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China
- 4 School of Health Economics and Management, Nanjing University of Chinese Medicine, Nanjing, China
Abstract
Objective: To put forward suggestions to improve the linkage mechanism between China’s essential medicine list and healthcare insurance medicine list. Methods: Comparative study of the organization setting, selection criteria, adjustment procedures, and reimbursement of essential medicine list and healthcare insurance medicine list, containing both the foreign experience and China’s status quo. Results: When two lists exist at the same time, they are often managed separately abroad, setting more selection criteria for the essential medicine, and giving the essential medicine a higher payment ratio. The two lists in China are managed and adjusted separately, but lack of con nection . As a result, some essential medicines cannot be reimbursed . Conclusion: The two lists’ linkage mechanism needs to be improved. It is recommended to make it clear that essential medicines should be selected from the healthcare insurance medicine list, and enhance the consistency of medicine evaluation through mutually scientific evidence.
- Culig, J., Antolic, S. and Szkultecka-Dbek, M. (2017) Drug Policy in Croatia. Value in Health Regional Issues, 13, 27-30. https://doi.org/10.1016/j.vhri.2017.07.005
- Pei, J., Lu, Y., Zhou, P., et al. (2018) The Development and Enlightenment of Sweden’s Essential Medicines List. Health Economics Research, 376, 49-51.
- Sun, J., Jiang, F. and Liu, Y.-L. (2017) The Successful Experiences of a Developing Country in Achieving Universal Access to Expensive Life-Saving Medicines and Its Implications to China. China Pharmacy, 28, 289-294.
- Santos-Pinto, C., Ventura, M., Pepe, V., et al. (2013) Essential Medicines and Technology Incorporation Following Novel Brazilian Public Health System Regulations. Cadernos de saúde pública/Ministério da Saúde, Fundação Oswaldo Cruz, Escola Nacional de Saúde Pública, 29, 1056-1058. https://doi.org/10.1590/S0102-311X2013000600002
- South Africa Government (2003) National Health Act. National Health Insurance Policy, 8, 18-21.
- South Africa Government (2020) National Essential Medicines List Fourth Edition.
- National Healthcare Security and Administration (2020) Announcement on the Publication of the “2020 National Healthcare Security Medicine List Adjustment Work Plan”. http://www.nhsa.gov.cn/art/2020/8/17/art_37_3407.html